Hospital, Oncology Centre and Procurement Supply in Oman

Supplying licensed establishments in Oman: the documentation pack, batch traceability, cold chain and compliance with MOH Oman requirements. No pricing published.

Prescription-only medicine. No pricing is published on this page. Prescription-medicine pricing is not advertised to the public in this market.

This page is informational and is not an advertisement, a promotional communication, or medical advice. It does not offer any medicine for sale to the public. Treatment decisions belong to your treating physician.

Who this page is for

Licensed government and private hospitals
Oncology centres and day-care treatment units
Licensed specialty pharmacies
Procurement and supply-chain departments

The documentation pack that accompanies each consignment

Certificate of origin for the product
Manufacturer's batch certificate of analysis (CoA)
Proforma invoice stating trade name, active ingredient, concentration, quantity, batch numbers and expiry dates
Continuous temperature record for that specific consignment for refrigerated products (2–8 °C)
Batch traceability data, with pack-level GS1 DataMatrix verification available
Licensed Türkiye supplier details and responsible pharmacist details

The regulatory position in Oman

Medicines in the Sultanate of Oman are regulated by the Ministry of Health, through the Directorate General of Pharmaceutical Affairs and Drug Control. Registration, importation, storage and distribution of pharmaceutical products all fall within that directorate's remit, and every product described on this page is a prescription-only medicine.

We have not verified Oman's personal-import procedure from a primary source, so we do not describe one. There is no step-by-step process set out on this page and nothing here should be read as an account of what the Ministry requires. Requirements must be confirmed directly with the Ministry of Health before any step is taken.

What we can describe is the general concept that applies across the region: a named-patient supply. A named-patient supply is a quantity of a prescription medicine intended for one identified patient, requested by that patient's treating physician, documented by a prescription and a medical report, and handled through licensed channels with the cold chain and batch traceability intact. It is not a commercial sale to the public and it is not a substitute for a locally registered product where one is available.

Assembling the documentation below before approaching the Ministry usually shortens the exchange, whichever route the Directorate General confirms applies to a given product.

We have not verified Oman's personal-import procedure. We do not describe one here. Confirm the current requirements with the Ministry of Health, Directorate General of Pharmaceutical Affairs and Drug Control.

Official sources

Background reading

Prescription-based enquiry

If you hold a valid prescription from a treating physician in Oman, you can send us the prescription details and we will reply with the regulatory and documentation position for that specific product. We do not publish pricing for Oman and we do not sell to the public.

Send a prescription-based enquiry

Medically reviewed by Pharmacy Remedy Pharmacovigilance & Compliance Desk · Last updated: 2026-07-29